Clinical Trial: Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07234890) titled 'Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.' on Sept. 25.

Brief Summary: Cognitive decline is increasingly recognized among patients receiving maintenance hemodialysis (HD). This can include trouble remembering, slower thinking or mentally feeling foggy.

This research is being done to determine if a new medication (AV-001) can protect the brain from injury caused by hemodialysis by strengthening blood vessels in the brain and reducing inflammation.

If successful, this research could lead to better protection for the brains of people undergoing regular dialysis, potentially reducing the risk of cognitive dec...